Form 4 for GLSI Greenwich LifeSciences, Inc.
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-06 · accession 0001493152-25-001298 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-08 | 2025-01-06+ | GLSI | Patel Snehal | CEO, CFO, Dir, 10% | P - Purchase | $13.58 | +2,900 | 5.55M | +0.1% | +$39.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-07 | P | A | 1,800 | $13.75 | 5,550,002 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-06 | P | A | 1,100 | $13.31 | 5,548,202 | D | — | — |